Michael G. Kauffman

2016

In 2016, Michael G. Kauffman earned a total compensation of $1.5M as Chief Executive Officer at Karyopharm Therapeutics, a 66% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$247,200
Option Awards$758,523
Salary$515,000
Other$11,260
Total$1,531,983

Kauffman received $758.5K in option awards, accounting for 50% of the total pay in 2016.

Kauffman also received $247.2K in non-equity incentive plan, $515K in salary and $11.3K in other compensation.

Rankings

In 2016, Michael G. Kauffman's compensation ranked 6,151st out of 14,075 executives tracked by ExecPay. In other words, Kauffman earned more than 56.3% of executives.

ClassificationRankingPercentile
All
6,151
out of 14,075
56th
Division
Manufacturing
2,253
out of 5,489
59th
Major group
Chemicals And Allied Products
741
out of 1,895
61st
Industry group
Drugs
561
out of 1,538
64th
Industry
Pharmaceutical Preparations
440
out of 1,176
63rd
Source: SEC filing on April 28, 2017.

Kauffman's colleagues

We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2016.

2016

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2016

Justin Renz

Karyopharm Therapeutics

Chief Financial Officer

2016

Christopher Primiano

Karyopharm Therapeutics

General Counsel

News

You may also like